- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- March 2024
- 196 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 193 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- March 2024
- 186 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- May 2023
- 175 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- April 2024
- 528 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- September 2023
- 215 Pages
Global
From €4030EUR$4,175USD£3,457GBP
- Report
- January 2024
- 120 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- June 2023
- 175 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- April 2024
- 89 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- October 2023
- 184 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- November 2023
- 182 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- February 2024
- 123 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 179 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 164 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 112 Pages
Global
From €4585EUR$4,750USD£3,933GBP
The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more